Cresco Labs (CRLBF) Retained Earnings (2019 - 2026)
Cresco Labs (CRLBF) posted Retained Earnings of -$1.5 billion for Q1 2026, down 1.04% on a QoQ basis from -$1.5 billion in Q4 2025, and down 10.7% year-over-year from -$1.7 billion in Q1 2025.
Cresco Labs (CRLBF) Retained Earnings (2019 - 2026) Analysis & Trends
Cresco Labs' Retained Earnings history runs 8 years deep, the most recent figure standing at -$1.5 billion for Q1 2026.
- Quarterly Retained Earnings fell 10.7% year-over-year to -$1.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.5 billion (down 10.7% YoY) and the FY2025 annual result came in at -$1.5 billion, down 67115.23% from the prior year.
- Retained Earnings was -$1.5 billion for Q1 2026 at Cresco Labs, down from -$1.5 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $82.9 million in Q4 2023 and bottomed at -$1.5 billion in Q1 2026.
- A 5-year average of -$1.0 billion and a median of -$1.3 billion in 2023 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2023 — Retained Earnings soared 6053.12% — and 2025, when it slumped 67115.23%.
- Cresco Labs' Retained Earnings stood at -$1.4 million in 2022, then surged by 6053.12% to $82.9 million in 2023, then plunged by 102.69% to -$2.2 million in 2024, then slumped by 67115.23% to -$1.5 billion in 2025, then retreated by 1.04% to -$1.5 billion in 2026.
- Business Quant data shows CRLBF's Retained Earnings at -$1.5 billion in Q1 2026, -$1.5 billion in Q4 2025, and -$1.4 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn | 8.83 Bn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | -413.76 Mn |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Cresco Labs | 242.58 Mn | 179.00 Mn | 75.45 Mn | -1.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.52 Bn |
| Dec 31, 2025 | -1.50 Bn |
| Sep 30, 2025 | -1.41 Bn |
| Jun 30, 2025 | -1.39 Bn |
| Mar 31, 2025 | -1.37 Bn |
| Dec 31, 2024 | -2.23 Mn |
| Sep 30, 2024 | -1.35 Bn |
| Jun 30, 2024 | -1.34 Bn |
| Mar 31, 2024 | -1.27 Bn |
| Dec 31, 2023 | 82.93 Mn |
| Sep 30, 2023 | -1.27 Bn |
| Jun 30, 2023 | -1.15 Bn |
| Mar 31, 2023 | -1.11 Bn |
| Dec 31, 2022 | -1.39 Mn |
| Sep 30, 2022 | -915.26 Mn |
| Jun 30, 2022 | -900.03 Mn |
| Mar 31, 2022 | -880.40 Mn |
| Dec 31, 2021 | -841.91 Mn |
| Sep 30, 2021 | -813.06 Mn |
| Mar 31, 2021 | -443.23 Mn |